Labcorp Holdings
$308.49Change from previous close: +1.28%Absolute change: +$3.89
At a glance
- Revenue growth
- +7.25%
- 2025 vs 2024
- Net income growth
- +17.49%
- 2025 vs 2024
- Net margin
- 6.3%
- 2024: 5.7%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 13,952 | 13,009 | 12,162 | 11,864 |
| Cost of revenue | 9,939 | 9,385 | 8,797 | 8,155 |
| Gross profit | 4,013 | 3,624 | 3,365 | 3,709 |
| Selling, general and administrative | 2,216 | 2,230 | 2,021 | 1,763 |
| Operating income | 1,516 | 1,138 | 1,124 | 1,752 |
| EBIT | 1,332 | 1,168 | 769 | 1,417 |
| EBITDA | 2,013 | 1,811 | 1,346 | 1,954 |
| Interest expense | 224 | 208 | 200 | 180 |
| Pre-tax income | 1,108 | 960 | 569 | 1,237 |
| Income tax | 230 | 212 | 189 | 234 |
| Net income | 877 | 746 | 418 | 1,279 |
| Net income to common shareholders | 877 | 746 | 418 | 1,279 |
| Basic EPS | 10.54 | 8.89 | 4.80 | 14.05 |
| Diluted EPS | 10.46 | 8.84 | 4.77 | 13.97 |
| Average shares (basic) | 83.2 | 83.9 | 87.1 | 91.1 |
| Average shares (diluted) | 83.8 | 84.4 | 87.6 | 91.6 |